351 related articles for article (PubMed ID: 17450623)
1. Antidepressants and psychosis in Parkinson disease: a case series.
Voon V; Fox S; Butler TR; Lang AE
Int J Geriatr Psychiatry; 2007 Jun; 22(6):601-4. PubMed ID: 17450623
[No Abstract] [Full Text] [Related]
2. Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
Meco G; Bernardi S
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):311-3. PubMed ID: 16919377
[TBL] [Abstract][Full Text] [Related]
3. Anxiety, depression, and psychosis in Parkinson's disease: unmet needs and treatment challenges.
Chen JJ
Neurol Clin; 2004 Oct; 22(3 Suppl):S63-90. PubMed ID: 15501367
[No Abstract] [Full Text] [Related]
4. The emergency treatment of depression complicated by psychosis or agitation.
Glick RL; Ghaemi SN
J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
[TBL] [Abstract][Full Text] [Related]
5. Summary: defining remission in patients treated with antidepressants.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 22():35-6. PubMed ID: 10634354
[No Abstract] [Full Text] [Related]
6. Introduction: defining remission in patients treated with antidepressants.
Thase ME
J Clin Psychiatry; 1999; 60 Suppl 22():3-6. PubMed ID: 10634348
[No Abstract] [Full Text] [Related]
7. Sertraline for the treatment of depression in Parkinson's disease.
Meara J; Hobson P
Mov Disord; 1998 May; 13(3):622. PubMed ID: 9613775
[No Abstract] [Full Text] [Related]
8. [Changes in disordered motor skills in depressed right handed patients due to antidepressive therapy].
Fabisch H; Wieselmann G; Fabisch K; Marguc K; Langs G; Zapotoczky HG
Wien Klin Wochenschr; 1993; 105(2):53-5. PubMed ID: 8095118
[TBL] [Abstract][Full Text] [Related]
9. Hyperprolactinaemia with amisulpride.
Ružić K; Grahovac T; Graovac M; Dadić-Hero E; Sepić-Grahovac D; Sabljić V
Psychiatr Danub; 2011 Mar; 23(1):92-4. PubMed ID: 21448106
[TBL] [Abstract][Full Text] [Related]
10. [How should mentally handicapped adults with depressive disorders be treated psychopharmacologically?].
Meins W
Nervenarzt; 1996 Mar; 67(3):216-8. PubMed ID: 8901279
[TBL] [Abstract][Full Text] [Related]
11. [Current indications for antidepressants].
Tignol J
Encephale; 1994 Jun; 20 Spec No 2():261-3. PubMed ID: 8088242
[No Abstract] [Full Text] [Related]
12. The presence of depression and anxiety in Parkinson's disease.
Mercury MG; Tschan W; Kehoe R; Kuechler A
Dis Mon; 2007 May; 53(5):296-301. PubMed ID: 17656191
[No Abstract] [Full Text] [Related]
13. Case report: Effective treatment of Cotard's syndrome: quetiapine in combination with venlafaxine.
Chan JH; Chen CH; Robson D; Tan HK
Psychiatry Clin Neurosci; 2009 Feb; 63(1):125-6. PubMed ID: 19154221
[No Abstract] [Full Text] [Related]
14. Depression and dementia in Parkinson's disease. Catecholamine changes in the locus ceruleus, a basis for therapy.
Chan-Palay V
Adv Neurol; 1993; 60():438-46. PubMed ID: 8093581
[No Abstract] [Full Text] [Related]
15. [Effects of antidepressants on symptoms, of inhibition].
de Carvalho W
Encephale; 1998; 24(5):456-61. PubMed ID: 9850820
[No Abstract] [Full Text] [Related]
16. [Age at initial use of antidepressive drugs].
Bouvard MP
Encephale; 1994 Jun; 20 Spec No 2():287-90. PubMed ID: 8088249
[No Abstract] [Full Text] [Related]
17. Mirtazapine improves visual hallucinations in Parkinson's disease: a case report.
Tagai K; Nagata T; Shinagawa S; Tsuno N; Ozone M; Nakayama K
Psychogeriatrics; 2013 Jun; 13(2):103-7. PubMed ID: 23909968
[TBL] [Abstract][Full Text] [Related]
18. [Psychological and cognitive problems in Parkinson disease--therapeutic possibilities].
Baronti F
Praxis (Bern 1994); 2002 Mar; 91(10):411-7. PubMed ID: 11933648
[TBL] [Abstract][Full Text] [Related]
19. [Antidepressive agents: benefits/risks].
Cuche H; Gérard A
Encephale; 1994 Apr; 20 Spec No 1():203-7. PubMed ID: 8039458
[TBL] [Abstract][Full Text] [Related]
20. The mousetrap: managing the placebo effect in antidepressant trials.
Lakoff A
Mol Interv; 2002 Apr; 2(2):72-6. PubMed ID: 14993352
[No Abstract] [Full Text] [Related]
[Next] [New Search]
